Glenmark Pharma Q1 Results: Net profit falls 18% to Rs 173.13 crore
Glenmark Pharmaceuticals Ltd on Friday reported an 18 per cent decline in consolidated net profit at Rs 173.13 crore in the first quarter ended June 30, 2023, impacted by higher expenses.
The company had posted a consolidated net profit of Rs 211.1 crore in the same quarter last fiscal, Glenmark Pharmaceuticals said in a regulatory filing. Image Source: Pixabay